| NCT Number | NCT07629869 |
| Lead Sponsor | Tel-Aviv Sourasky Medical Center
Collaborators: AstraZeneca |
| Conditions | COPD, COPD Exacerbation (AECOPD) |
| Enrollment | 240 participants |
| Start Date | 2026-07-01 |
| Primary Completion | 2028-12-31 (estimated) |
| Study Completion | 2028-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-23 |